Aspen Aerogels(US:ASPN) Zacks Investment Researchยท2024-02-13 00:05Financial Performance - Aspen Aerogels reported a quarterly loss of $0.01 per share, better than the Zacks Consensus Estimate of a loss of $0.12, and an improvement from a loss of $0.20 per share a year ago, indicating a significant earnings surprise of 91.67% [1] - The company achieved revenues of $84.22 million for the quarter ended December 2023, surpassing the Zacks Consensus Estimate by 0.47%, and showing a year-over-year increase from $59.61 million [1] - Over the last four quarters, Aspen Aerogels has exceeded consensus EPS estimates four times and topped consensus revenue estimates three times [1] Stock Performance and Outlook - Aspen Aerogels shares have declined approximately 24% since the beginning of the year, contrasting with the S&P 500's gain of 5.4% [2] - The future performance of Aspen Aerogels' stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [2] - The current consensus EPS estimate for the upcoming quarter is -$0.09 on revenues of $78.44 million, and for the current fiscal year, it is -$0.15 on revenues of $354.51 million [4] Industry Context - The Building Products - Miscellaneous industry, to which Aspen Aerogels belongs, is currently ranked in the top 15% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [4] - The performance of Aspen Aerogels may also be influenced by the overall industry outlook, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [4] - CaesarStone, another company in the same industry, is expected to report a quarterly loss of $0.14 per share, reflecting a significant year-over-year decline, with revenues projected at $124.94 million, down 21.6% from the previous year [5]